Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Folinic Acid in Children With Autism Spectrum Disorders (EFFET)
NCT02551380Phase 2Unknown
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Oct 2015
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
A Phase 2 trial of folinic acid in Autism Spectrum Disorder (ASD), sponsored by CHRU de Nancy - Hôpital Central. Status: unknown.
02
Drugs
folinic acid
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT02551380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02551380.